van de Weijer P - Search Results

1

Tibolone and low-dose continuous combined hormone treatment: vaginal bleeding pattern, efficacy and tolerability.

Hammar ML, van de Weijer P, Franke HR, Pornel B, von Mauw EM, Nijland EA; TOTAL Study Investigators Group. Hammar ML, et al. Among authors: van de weijer p. BJOG. 2007 Dec;114(12):1522-9. doi: 10.1111/j.1471-0528.2007.01537.x. BJOG. 2007. PMID: 17995496 Clinical Trial.

2

Improved bleeding profile and tolerability of tibolone versus transdermal E2/NETA treatment in postmenopausal women with female sexual dysfunction.

Nijland EA, Nathorst-Böös J, Palacios S, van de Weijer PW, Davis S, Stathopoulos VM, Birkhaeuser MH, von Mauw E, Mulder RJ, Schultz WC; LISA study investigators group. Nijland EA, et al. Among authors: van de weijer pw. Climacteric. 2009 Apr;12(2):114-21. doi: 10.1080/13697130802576666. Climacteric. 2009. PMID: 19177255 Clinical Trial.

3

Adopting innovation in gynaecology: The introduction of e-consult.

Mann R, van de Weijer PHM. Mann R, et al. Among authors: van de weijer phm. Aust N Z J Obstet Gynaecol. 2018 Aug;58(4):449-453. doi: 10.1111/ajo.12764. Epub 2018 Jan 12. Aust N Z J Obstet Gynaecol. 2018. PMID: 29327350

4

Stress Management in Thin-Film Gas-Permeation Barriers.

Behrendt A, Meyer J, van de Weijer P, Gahlmann T, Heiderhoff R, Riedl T. Behrendt A, et al. Among authors: van de weijer p. ACS Appl Mater Interfaces. 2016 Feb 17;8(6):4056-61. doi: 10.1021/acsami.5b11499. Epub 2016 Feb 2. ACS Appl Mater Interfaces. 2016. PMID: 26790836

5

A phase II dose-ranging study of mirabegron in patients with overactive bladder.

Chapple CR, Dvorak V, Radziszewski P, Van Kerrebroeck P, Wyndaele JJ, Bosman B, Boerrigter P, Drogendijk T, Ridder A, Van Der Putten-Slob I, Yamaguchi O; Dragon Investigator Group. Chapple CR, et al. Int Urogynecol J. 2013 Sep;24(9):1447-58. doi: 10.1007/s00192-013-2042-x. Epub 2013 Mar 8. Int Urogynecol J. 2013. PMID: 23471546 Free PMC article. Clinical Trial.

6

Risks of hormone therapy in the 50-59 year age group.

van de Weijer PH. van de Weijer PH. Maturitas. 2008 May 20;60(1):59-64. doi: 10.1016/j.maturitas.2008.04.010. Epub 2008 Jun 16. Maturitas. 2008. PMID: 18556157 Review.

7

What is the recurrence rate of postmenopausal bleeding in women who have a thin endometrium during a first episode of postmenopausal bleeding?

Van Doorn HC, Timmermans A, Opmeer BC, Kruitwagen RF, Dijkhuizen FP, Kooi GS, Van De Weijer PH, Mol BW, Dupomeb F. Van Doorn HC, et al. Among authors: van de weijer ph. Acta Obstet Gynecol Scand. 2008;87(1):89-93. doi: 10.1080/00016340701763130. Acta Obstet Gynecol Scand. 2008. PMID: 18158632 Free article.

8

Benefits and risks of long-term low-dose oral continuous combined hormone therapy.

van de Weijer PH, Mattsson LA, Ylikorkala O. van de Weijer PH, et al. Maturitas. 2007 Mar 20;56(3):231-48. doi: 10.1016/j.maturitas.2006.08.004. Epub 2006 Oct 10. Maturitas. 2007. PMID: 17034966 Review.

9

Complementary and hormonal therapy for vasomotor symptom relief: a conservative clinical approach.

Nachtigall LE, Baber RJ, Barentsen R, Durand N, Panay N, Pitkin J, van de Weijer PHM, Wysocki S. Nachtigall LE, et al. Among authors: van de weijer phm. J Obstet Gynaecol Can. 2006 Apr;28(4):279-289. doi: 10.1016/S1701-2163(16)32136-3. J Obstet Gynaecol Can. 2006. PMID: 16776904 Review.

10

Intranasal continuous combined 17 beta-estradiol/norethisterone therapy improves the lipid profile in healthy postmenopausal women.

Hemelaar M, Kenemans P, de Bie L, van de Weijer PH, van der Mooren MJ. Hemelaar M, et al. Among authors: van de weijer ph. Fertil Steril. 2006 Apr;85(4):979-88. doi: 10.1016/j.fertnstert.2005.09.036. Fertil Steril. 2006. PMID: 16580384 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page